美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Artiva Biotherapeutics, Inc.

11.52

+0.59005.40%

盤前：11.530.0100+0.09%08:26 EDT

成交量：30.72萬

成交額：347.10萬

市值：5.63億

市盈率：-3.59

高：11.70

開：10.83

低：10.49

收：10.93

52周最高：14.53

52周最低：2.22

股本：4,888.58萬

流通股本：1,989.95萬

量比：1.01

換手率：1.54%

股息：- -

股息率：- -

每股收益(TTM):-3.2084

每股收益(LYR):-3.4309

淨資產收益率：-36.58%

總資產收益率：-22.34%

市淨率：1.62

市盈率(LYR):-3.36

資料載入中...

總覽公司新聞資訊公告

Artiva Biotherapeutics將在Eular 2026大會上展示多項Allonk®數據，包括一項突破性口頭報告，其臨床療效媲美自體CAR-T細胞療法

Artiva Biotherapeutics完成3億美元普通股及預先注資認股權證承銷發行定價

Artiva Biotherapeutics公司定價發行2390萬股普通股每股11.52美元及220萬份預融資權證每股11.5199美元

熱門話題-Artiva股價大漲，因細胞療法在類風濕性關節炎治療中顯示出療效

Artiva Biotherapeutics暫停與Leerink Partners達成的普通股銷售協議

Artiva Biotherapeutics公司現金儲備達8680萬美元資金可支撐運營至2027年第二季度

Artiva公布Allonk®治療多種自身免疫疾病的積極初期臨床數據，並與FDA達成共識擬於2026年啓動類風濕關節炎三期註冊試驗

Artiva Biotherapeutics公司早期數據：難治性類風濕關節炎患者六個月時ACR50應答率達71%

Artiva Biotherapeutics公司Allonk療法展現良好耐受性，未現CRS、ICANS或停藥案例

Artiva Biotherapeutics Inc預計於2026年下半年啓動註冊性試驗，關鍵數據將於2028年下半年公布

Artiva Biotherapeutics, Inc.盤中異動大幅上漲5.12%報5.75美元

Artiva Biotherapeutics, Inc.盤中異動下午盤大幅拉升5.47%

Artiva Biotherapeutics任命Thad Huston為首席財務官並授予入職獎勵股權

Artiva Biotherapeutics任命Thad Huston為首席財務官並授予入職獎勵股權

Artiva Biotherapeutics, Inc.盤中異動快速上漲6.20%報4.97美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/ARTV/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARTV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTV\",,,,,undefined,":{"symbol":"ARTV","market":"US","secType":"STK","nameCN":"Artiva Biotherapeutics, Inc.","latestPrice":11.52,"timestamp":1787601600000,"preClose":10.93,"halted":0,"volume":307236,"hourTrading":{"tag":"盘前","latestPrice":11.53,"preClose":11.52,"latestTime":"08:26 EDT","volume":770,"amount":8844.240020000001,"timestamp":1787660814223,"change":0.01,"changeRate":0.000868,"amplitude":0.013021},"delay":0,"changeRate":0.05397987191216833,"floatShares":19899500,"shares":48885777,"eps":-3.20842,"marketStatus":"盤前交易","change":0.59,"latestTime":"08-25 08:30:08 EDT","open":10.83,"high":11.7,"low":10.49,"amount":3470994.408696,"amplitude":0.110704,"askPrice":11.8,"askSize":50,"bidPrice":10.34,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.20842,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1787664600000},"marketStatusCode":1,"adr":0,"listingDate":1721361600000,"exchange":"NASDAQ","adjPreClose":11.52,"preHourTrading":{"tag":"盘前","latestPrice":11.53,"preClose":11.52,"latestTime":"08:26 EDT","volume":770,"amount":8844.240020000001,"timestamp":1787660814223,"change":0.01,"changeRate":0.000868,"amplitude":0.013021},"postHourTrading":{"tag":"盘后","latestPrice":11.68,"preClose":11.52,"latestTime":"19:51 EDT","volume":18775,"amount":216297.0447,"timestamp":1787615480012,"change":0.16,"changeRate":0.013889,"amplitude":0.013889},"volumeRatio":1.0058714794192027,"impliedVol":2.0918,"impliedVolPercentile":1},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTV\",,,,,undefined,":{"symbol":"ARTV","floatShares":19899500,"roa":"-22.34%","roe":"-36.58%","lyrEps":-3.430895,"volumeRatio":1.0058714794192027,"shares":48885777,"dividePrice":0,"high":11.7,"amplitude":0.110704,"preClose":10.93,"low":10.49,"week52Low":2.22,"pbRate":"1.62","week52High":14.53,"institutionHeld":0,"latestPrice":11.52,"committee":0.333333,"eps":-3.20842,"divideRate":0,"volume":307236,"delay":0,"ttmEps":-3.20842,"open":10.83,"prevYearClose":4.29,"prevWeekClose":10.93,"prevMonthClose":10.1,"prevQuarterClose":9.7,"fiveDayClose":11.74,"twentyDayClose":10.32,"sixtyDayClose":7.61},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARTV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"ARTV","fiscalQuarterEnding":"2026/06","expectedEps":-0.64,"name":null,"time":"盤後","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-0.63},{"market":"US","date":"2026-05-08","symbol":"ARTV","fiscalQuarterEnding":"2026/03","expectedEps":-0.88,"name":null,"time":"盤前","type":"earning","dateTimestamp":1778212800000,"reportTimeType":"pre","actualEps":-0.95},{"market":"US","date":"2026-03-10","symbol":"ARTV","fiscalQuarterEnding":"2025/12","expectedEps":-0.87,"name":null,"time":"盤後","type":"earning","dateTimestamp":1773115200000,"reportTimeType":"post","actualEps":-0.84},{"market":"US","date":"2025-11-12","symbol":"ARTV","fiscalQuarterEnding":"2025/09","expectedEps":-0.92,"name":null,"time":"盤前","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.88},{"market":"US","date":"2025-08-06","symbol":"ARTV","fiscalQuarterEnding":"2025/06","expectedEps":-0.84,"name":null,"time":"盤後","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-0.87}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARTV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARTV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1735790400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ARTV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ARTV","date":"2026-08-21","current":-3.590552,"percent":0.164063,"low":-11.820615,"twenty":-5.366075,"median":-1.692595,"eighty":-0.938902,"high":-0.499349,"avg":-3.236324,"sd":2.976381,"marketCap":544635947},"quantilePoints":[{"date":"2024-08-02","current":-10.391793,"twenty":-10.391793,"median":-10.391793,"eighty":-10.391793,"marketCap":269833291},{"date":"2024-08-09","current":-9.862789,"twenty":-10.391793,"median":-10.042112,"eighty":-9.943484,"marketCap":256097171},{"date":"2024-08-16","current":-10.185571,"twenty":-10.248334,"median":-10.131774,"eighty":-9.95245,"marketCap":264478532},{"date":"2024-08-23","current":-8.939273,"twenty":-10.248334,"median":-10.051078,"eighty":-9.342751,"marketCap":232117163},{"date":"2024-08-30","current":-8.088598,"twenty":-10.185571,"median":-9.943484,"eighty":-9.046867,"marketCap":263081639},{"date":"2024-09-06","current":-8.893463,"twenty":-10.142533,"median":-9.800025,"eighty":-8.930111,"marketCap":289259885},{"date":"2024-09-13","current":-8.019798,"twenty":-10.131774,"median":-9.459311,"eighty":-8.763533,"marketCap":260843926},{"date":"2024-09-20","current":-8.759053,"twenty":-10.07439,"median":-9.028935,"eighty":-8.450238,"marketCap":284888199},{"date":"2024-09-27","current":-9.946342,"twenty":-10.07439,"median":-9.323455,"eighty":-8.581333,"marketCap":323504758},{"date":"2024-10-04","current":-11.499524,"twenty":-10.277026,"median":-9.57298,"eighty":-8.727691,"marketCap":374022017},{"date":"2024-10-11","current":-10.566121,"twenty":-10.505561,"median":-9.728296,"eighty":-8.794895,"marketCap":343663087},{"date":"2024-10-18","current":-9.543111,"twenty":-10.587029,"median":-9.800025,"eighty":-8.869568,"marketCap":310389700},{"date":"2024-10-25","current":-7.586699,"twenty":-10.505561,"median":-9.574426,"eighty":-8.581333,"marketCap":246757383},{"date":"2024-10-31","current":-7.579232,"twenty":-10.485041,"median":-9.464706,"eighty":-8.226879,"marketCap":246514511},{"date":"2024-11-08","current":-10.424244,"twenty":-10.485041,"median":-9.3863,"eighty":-8.226879,"marketCap":339048530},{"date":"2024-11-15","current":-4.166082,"twenty":-10.46953,"median":-9.378833,"eighty":-8.149728,"marketCap":255280837},{"date":"2024-11-22","current":-4.310765,"twenty":-10.439178,"median":-9.30416,"eighty":-7.969021,"marketCap":264146442},{"date":"2024-11-29","current":-5.065892,"twenty":-10.411264,"median":-9.046867,"eighty":-7.81669,"marketCap":310417611},{"date":"2024-12-06","current":-4.598149,"twenty":-10.334409,"median":-8.970887,"eighty":-7.365669,"marketCap":281756204},{"date":"2024-12-13","current":-4.233469,"twenty":-10.223229,"median":-8.939273,"eighty":-5.058757,"marketCap":259410023},{"date":"2024-12-20","current":-3.963922,"twenty":-10.173512,"median":-8.885996,"eighty":-4.852633,"marketCap":242893280},{"date":"2024-12-27","current":-4.17401,"twenty":-10.150694,"median":-8.781454,"eighty":-4.667914,"marketCap":255766623},{"date":"2025-01-03","current":-3.95203,"twenty":-10.131774,"median":-8.549971,"eighty":-4.598149,"marketCap":242164600},{"date":"2025-01-10","current":-4.066984,"twenty":-10.131774,"median":-8.396892,"eighty":-4.398368,"marketCap":249208505},{"date":"2025-01-17","current":-2.687539,"twenty":-10.07439,"median":-8.17661,"eighty":-4.337719,"marketCap":164681643},{"date":"2025-01-24","current":-2.477451,"twenty":-10.049285,"median":-8.109405,"eighty":-4.224748,"marketCap":151808300},{"date":"2025-01-31","current":-2.140518,"twenty":-10.011532,"median":-8.012331,"eighty":-4.193829,"marketCap":131162371},{"date":"2025-02-07","current":-1.823404,"twenty":-9.967928,"median":-7.881014,"eighty":-4.108209,"marketCap":111730908},{"date":"2025-02-14","current":-1.589533,"twenty":-9.948785,"median":-7.698708,"eighty":-3.978192,"marketCap":97400205},{"date":"2025-02-21","current":-1.502326,"twenty":-9.945199,"median":-7.508293,"eighty":-3.804572,"marketCap":92056553},{"date":"2025-02-28","current":-1.478543,"twenty":-9.911206,"median":-5.18038,"eighty":-2.77871,"marketCap":90599193},{"date":"2025-03-07","current":-2.0216,"twenty":-9.837683,"median":-5.059946,"eighty":-2.521847,"marketCap":123875572},{"date":"2025-03-14","current":-2.219796,"twenty":-9.795827,"median":-4.998506,"eighty":-2.343471,"marketCap":136020236},{"date":"2025-03-21","current":-1.601424,"twenty":-9.736345,"median":-4.76067,"eighty":-2.165887,"marketCap":98128885},{"date":"2025-03-28","current":-1.319282,"twenty":-9.624289,"median":-4.665536,"eighty":-2.054897,"marketCap":86245441},{"date":"2025-04-04","current":-0.946604,"twenty":-9.574715,"median":-4.606077,"eighty":-1.965312,"marketCap":61882322},{"date":"2025-04-11","current":-0.685729,"twenty":-9.561032,"median":-4.439593,"eighty":-1.797242,"marketCap":44828138},{"date":"2025-04-17","current":-0.857161,"twenty":-9.511749,"median":-4.37617,"eighty":-1.744126,"marketCap":56035173},{"date":"2025-04-25","current":-0.913063,"twenty":-9.383313,"median":-4.344458,"eighty":-1.606181,"marketCap":59689641},{"date":"2025-05-02","current":-0.883248,"twenty":-9.365642,"median":-4.233469,"eighty":-1.560992,"marketCap":57740592},{"date":"2025-05-09","current":-0.740531,"twenty":-9.335033,"median":-4.213649,"eighty":-1.495984,"marketCap":53111599},{"date":"2025-05-16","current":-0.723546,"twenty":-9.26085,"median":-4.193829,"eighty":-1.480232,"marketCap":51893443},{"date":"2025-05-23","current":-0.672592,"twenty":-9.079462,"median":-4.170046,"eighty":-1.376675,"marketCap":48238975},{"date":"2025-05-30","current":-0.696371,"twenty":-9.046867,"median":-4.104641,"eighty":-1.177664,"marketCap":49944393},{"date":"2025-06-06","current":-0.665798,"twenty":-9.028935,"median":-3.995633,"eighty":-0.946604,"marketCap":47751713},{"date":"2025-06-13","current":-0.696371,"twenty":-8.975602,"median":-3.957976,"eighty":-0.913063,"marketCap":49944393},{"date":"2025-06-20","current":-0.570684,"twenty":-8.968058,"median":-3.829149,"eighty":-0.909336,"marketCap":40930039},{"date":"2025-06-27","current":-0.533318,"twenty":-8.961769,"median":-2.822312,"eighty":-0.881757,"marketCap":38250096},{"date":"2025-07-03","current":-0.546906,"twenty":-8.947831,"median":-2.762854,"eighty":-0.830328,"marketCap":39224621},{"date":"2025-07-11","current":-0.60805,"twenty":-8.911787,"median":-2.592405,"eighty":-0.73948,"marketCap":43609983},{"date":"2025-07-18","current":-0.879805,"twenty":-8.888983,"median":-2.477451,"eighty":-0.736237,"marketCap":63100478},{"date":"2025-07-25","current":-1.168544,"twenty":-8.885996,"median":-2.34466,"eighty":-0.73948,"marketCap":83809129},{"date":"2025-08-01","current":-1.019079,"twenty":-8.836712,"median":-2.219796,"eighty":-0.740531,"marketCap":73089357},{"date":"2025-08-08","current":-0.856075,"twenty":-8.776974,"median":-2.136554,"eighty":-0.74119,"marketCap":64318634},{"date":"2025-08-15","current":-0.877783,"twenty":-8.664966,"median":-2.104843,"eighty":-0.766227,"marketCap":65949557},{"date":"2025-08-22","current":-0.90054,"twenty":-8.539516,"median":-2.017636,"eighty":-0.794855,"marketCap":67659360},{"date":"2025-08-29","current":-1.027331,"twenty":-8.461857,"median":-1.938358,"eighty":-0.806285,"marketCap":77185407},{"date":"2025-09-05","current":-1.011075,"twenty":-8.405106,"median":-1.906646,"eighty":-0.809828,"marketCap":75964119},{"date":"2025-09-12","current":-0.864778,"twenty":-8.31765,"median":-1.769891,"eighty":-0.816568,"marketCap":64972526},{"date":"2025-09-19","current":-0.773749,"twenty":-8.226879,"median":-1.740162,"eighty":-0.790778,"marketCap":58133313},{"date":"2025-09-26","current":-0.978565,"twenty":-8.17661,"median":-1.635118,"eighty":-0.805192,"marketCap":73521543},{"date":"2025-10-03","current":-0.959059,"twenty":-8.149728,"median":-1.601424,"eighty":-0.809828,"marketCap":72055997},{"date":"2025-10-10","current":-0.975314,"twenty":-8.101082,"median":-1.571695,"eighty":-0.816568,"marketCap":73277286},{"date":"2025-10-17","current":-0.90054,"twenty":-8.061078,"median":-1.530074,"eighty":-0.825779,"marketCap":67659360},{"date":"2025-10-24","current":-1.573506,"twenty":-8.013824,"median":-1.539983,"eighty":-0.830317,"marketCap":118220688},{"date":"2025-10-31","current":-1.280912,"twenty":-7.969021,"median":-1.537745,"eighty":-0.833281,"marketCap":96237502},{"date":"2025-11-07","current":-1.11836,"twenty":-7.90156,"median":-1.498363,"eighty":-0.837688,"marketCap":84024621},{"date":"2025-11-14","current":-1.102105,"twenty":-7.858868,"median":-1.490435,"eighty":-0.847643,"marketCap":82803333},{"date":"2025-11-21","current":-0.982565,"twenty":-7.819676,"median":-1.476561,"eighty":-0.856509,"marketCap":77807345},{"date":"2025-11-28","current":-1.16544,"twenty":-7.765913,"median":-1.457948,"eighty":-0.858684,"marketCap":92288839},{"date":"2025-12-05","current":-1.170089,"twenty":-7.585206,"median":-1.427209,"eighty":-0.865066,"marketCap":92657012},{"date":"2025-12-12","current":-0.973266,"twenty":-7.550856,"median":-1.356118,"eighty":-0.866579,"marketCap":77070998},{"date":"2025-12-19","current":-1.441302,"twenty":-7.413459,"median":-1.35655,"eighty":-0.869582,"marketCap":114133803},{"date":"2025-12-26","current":-1.332817,"twenty":-7.317879,"median":-1.35655,"eighty":-0.875795,"marketCap":105543087},{"date":"2026-01-02","current":-1.329717,"twenty":-5.60788,"median":-1.355686,"eighty":-0.876285,"marketCap":105297638},{"date":"2026-01-09","current":-1.419605,"twenty":-5.08879,"median":-1.356118,"eighty":-0.877508,"marketCap":112415660},{"date":"2026-01-16","current":-1.38241,"twenty":-5.065892,"median":-1.373111,"eighty":-0.877783,"marketCap":109470271},{"date":"2026-01-23","current":-1.534289,"twenty":-5.058757,"median":-1.38241,"eighty":-0.877783,"marketCap":121497274},{"date":"2026-01-30","current":-1.286323,"twenty":-5.046865,"median":-1.38396,"eighty":-0.878996,"marketCap":101861351},{"date":"2026-02-06","current":-1.199535,"twenty":-5.015947,"median":-1.373111,"eighty":-0.880542,"marketCap":94988778},{"date":"2026-02-13","current":-1.23673,"twenty":-4.922398,"median":-1.361731,"eighty":-0.882362,"marketCap":97934166},{"date":"2026-02-20","current":-1.404107,"twenty":-4.858976,"median":-1.356118,"eighty":-0.88623,"marketCap":111188415},{"date":"2026-02-27","current":-1.689268,"twenty":-4.776526,"median":-1.370012,"eighty":-0.890736,"marketCap":133769726},{"date":"2026-03-06","current":-1.779155,"twenty":-4.679806,"median":-1.38241,"eighty":-0.892087,"marketCap":140887748},{"date":"2026-03-13","current":-1.989358,"twenty":-4.672671,"median":-1.404107,"eighty":-0.894194,"marketCap":166837536},{"date":"2026-03-20","current":-1.626853,"twenty":-4.654437,"median":-1.418531,"eighty":-0.895573,"marketCap":136436029},{"date":"2026-03-27","current":-1.520754,"twenty":-4.628275,"median":-1.425804,"eighty":-0.898589,"marketCap":127538027},{"date":"2026-04-02","current":-1.989358,"twenty":-4.610834,"median":-1.432003,"eighty":-0.90054,"marketCap":166837536},{"date":"2026-04-10","current":-2.004094,"twenty":-4.574366,"median":-1.4506,"eighty":-0.90119,"marketCap":168073369},{"date":"2026-04-17","current":-3.569056,"twenty":-4.471304,"median":-1.457173,"eighty":-0.904441,"marketCap":299318897},{"date":"2026-04-24","current":-3.330333,"twenty":-4.432458,"median":-1.470747,"eighty":-0.907501,"marketCap":279298393},{"date":"2026-05-01","current":-3.01793,"twenty":-4.398368,"median":-1.476546,"eighty":-0.909336,"marketCap":253098721},{"date":"2026-05-08","current":-3.689891,"twenty":-4.369828,"median":-1.481596,"eighty":-0.910081,"marketCap":309452733},{"date":"2026-05-15","current":-3.031745,"twenty":-4.344458,"median":-1.487795,"eighty":-0.913063,"marketCap":263974056},{"date":"2026-05-22","current":-4.458708,"twenty":-4.432458,"median":-1.494399,"eighty":-0.913063,"marketCap":388219702},{"date":"2026-05-29","current":-4.246654,"twenty":-4.403917,"median":-1.50281,"eighty":-0.913063,"marketCap":369756186},{"date":"2026-06-05","current":-4.285717,"twenty":-4.403917,"median":-1.512592,"eighty":-0.913063,"marketCap":373157360},{"date":"2026-06-12","current":-4.464288,"twenty":-4.403917,"median":-1.532182,"eighty":-0.913063,"marketCap":388705584},{"date":"2026-06-18","current":-5.546878,"twenty":-4.459824,"median":-1.539565,"eighty":-0.913448,"marketCap":482966688},{"date":"2026-06-26","current":-4.927458,"twenty":-4.618762,"median":-1.553857,"eighty":-0.916145,"marketCap":429033788},{"date":"2026-07-02","current":-5.468753,"twenty":-4.679014,"median":-1.559086,"eighty":-0.919028,"marketCap":476164340},{"date":"2026-07-10","current":-5.251119,"twenty":-4.852633,"median":-1.578076,"eighty":-0.922185,"marketCap":457214943},{"date":"2026-07-17","current":-5.044646,"twenty":-4.98936,"median":-1.593497,"eighty":-0.929149,"marketCap":439237309},{"date":"2026-07-24","current":-5.652905,"twenty":-5.058757,"median":-1.601424,"eighty":-0.93305,"marketCap":492198445},{"date":"2026-07-31","current":-5.820316,"twenty":-5.116075,"median":-1.607696,"eighty":-0.93435,"marketCap":506774905},{"date":"2026-08-07","current":-6.195168,"twenty":-5.189342,"median":-1.626853,"eighty":-0.936301,"marketCap":562651332},{"date":"2026-08-14","current":-6.082936,"twenty":-5.239958,"median":-1.667148,"eighty":-0.936301,"marketCap":552458367},{"date":"2026-08-21","current":-5.996806,"twenty":-5.366075,"median":-1.692595,"eighty":-0.938902,"marketCap":544635947}],"updateTime":1787644184768},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARTV\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1187390966","title":"Artiva Biotherapeutics將在Eular 2026大會上展示多項Allonk®數據，包括一項突破性口頭報告，其臨床療效媲美自體CAR-T細胞療法","url":"https://stock-news.laohu8.com/highlight/detail?id=1187390966","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187390966?lang=zh_tw&edition=fundamental","pubTime":"2026-05-20 04:06","pubTimestamp":1779221199,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics, Inc. 宣布，将在2026年欧洲抗风湿病联盟大会上，进行多项关于其Allonk®疗法的数据展示。其中，一项被列为“突破性”的口头报告尤为引人注目。该报告将重点展示Allonk®在风湿性疾病治疗中的临床疗效，其数据结果与目前使用的自体CAR-T细胞疗法表现相当。\n这一系列数据发布，标志着公司在同种异体细胞疗法领域取得了重要进展。通过在不同环节展示Allonk®的潜力，公司旨在向科学界和医学界全面呈现该疗法的优势与前景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107426732","title":"Artiva Biotherapeutics完成3億美元普通股及預先注資認股權證承銷發行定價","url":"https://stock-news.laohu8.com/highlight/detail?id=1107426732","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107426732?lang=zh_tw&edition=fundamental","pubTime":"2026-05-08 18:56","pubTimestamp":1778237809,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics, Inc. (简称Artiva) 已正式确定其总额达3亿美元的承销发行定价方案。此次发行包含普通股及预先注资认股权证的组合配售，标志着该公司资本运作的重要进展。通过此类融资手段，Artiva有望进一步强化其细胞治疗平台的研发投入与临床推进能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117389399","title":"Artiva Biotherapeutics公司定價發行2390萬股普通股 每股11.52美元及220萬份預融資權證 每股11.5199美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1117389399","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117389399?lang=zh_tw&edition=fundamental","pubTime":"2026-05-08 18:54","pubTimestamp":1778237655,"startTime":"0","endTime":"0","summary":"生物技术企业Artiva Biotherapeutics Inc（股票代码：ARTV）正式公布其新股发行定价方案。根据公告，公司将以每股11.52美元的价格公开发行2390万股普通股，同时以每股11.5199美元的定价配售220万份预融资权证。此次融资将为企业后续研发管线推进提供资金支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633437229","title":"熱門話題-Artiva股價大漲，因細胞療法在類風濕性關節炎治療中顯示出療效","url":"https://stock-news.laohu8.com/highlight/detail?id=2633437229","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633437229?lang=zh_tw&edition=fundamental","pubTime":"2026-05-08 18:48","pubTimestamp":1778237314,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL4S41L0WF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180304875","title":"Artiva Biotherapeutics暫停與Leerink Partners達成的普通股銷售協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1180304875","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180304875?lang=zh_tw&edition=fundamental","pubTime":"2026-05-08 18:42","pubTimestamp":1778236942,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics公司已根据提交给美国证券交易委员会的文件，暂停了其依据与Leerink Partners签订的销售协议进行的普通股发行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145868841","title":"Artiva Biotherapeutics公司現金儲備達8680萬美元 資金可支撐運營至2027年第二季度","url":"https://stock-news.laohu8.com/highlight/detail?id=1145868841","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145868841?lang=zh_tw&edition=fundamental","pubTime":"2026-05-08 18:35","pubTimestamp":1778236501,"startTime":"0","endTime":"0","summary":"截至2026年3月31日，Artiva Biotherapeutics公司持有的现金、现金等价物及投资总额达到8680万美元。这一充足的资金储备将确保公司运营持续至2027年第二季度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139365930","title":"Artiva公布Allonk®治療多種自身免疫疾病的積極初期臨床數據，並與FDA達成共識擬於2026年啓動類風濕關節炎三期註冊試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1139365930","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139365930?lang=zh_tw&edition=fundamental","pubTime":"2026-05-08 18:31","pubTimestamp":1778236316,"startTime":"0","endTime":"0","summary":"生物技术公司Artiva Biotherapeutics宣布，其核心产品Allonk®在针对多种自身免疫性疾病的早期临床研究中取得突破性进展。数据显示该疗法在安全性及有效性方面均表现出积极信号。与此同时，公司已与美国食品药品监督管理局（FDA）就开展类风湿关节炎的三期注册临床试验达成关键共识，预计将于2026年正式启动这项关键性研究。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123757407","title":"Artiva Biotherapeutics公司早期數據：難治性類風濕關節炎患者六個月時ACR50應答率達71%","url":"https://stock-news.laohu8.com/highlight/detail?id=1123757407","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123757407?lang=zh_tw&edition=fundamental","pubTime":"2026-05-08 18:31","pubTimestamp":1778236279,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics公司公布的最新初步研究数据显示，在针对难治性类风湿关节炎患者的临床试验中，接受治疗六个月后达到ACR50应答标准的患者比例高达71%。这一积极数据展现了该公司在细胞疗法领域的研发潜力。\nACR50是评估类风湿关节炎治疗效果的权威指标，代表患者症状和身体功能至少改善50%。对于现有疗法反应不佳的难治性患者群体而言，达到如此高比例的应答率具有重要临床意义。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136199055","title":"Artiva Biotherapeutics公司Allonk療法展現良好耐受性，未現CRS、ICANS或停藥案例","url":"https://stock-news.laohu8.com/highlight/detail?id=1136199055","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136199055?lang=zh_tw&edition=fundamental","pubTime":"2026-05-08 18:31","pubTimestamp":1778236278,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics公司（股票代码：ARTV）近日公布其候选疗法Allonk的最新研究数据。该疗法在临床试验中表现出优异的耐受性特征，全程未观察到细胞因子释放综合征（CRS）、免疫效应细胞相关神经毒性综合征（ICANS）等不良反应，亦无受试者因不良事件中止治疗。\n这一积极结果标志着Allonk在安全性方面取得重要突破，为后续临床开发奠定坚实基础。研究数据进一步验证了该疗法潜在的治疗窗口与可控的安全性轮廓，展现出良好的临床应用前景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199193235","title":"Artiva Biotherapeutics Inc預計於2026年下半年啓動註冊性試驗，關鍵數據將於2028年下半年公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1199193235","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199193235?lang=zh_tw&edition=fundamental","pubTime":"2026-05-08 18:31","pubTimestamp":1778236274,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics Inc宣布，其关键注册性临床试验预计将于2026年下半年正式启动，而试验的主要数据结果计划在2028年下半年对外公布。这一时间表的公布为投资者提供了公司研发管线推进的明确路线图。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617544306","title":"Artiva Biotherapeutics, Inc.盤中異動 大幅上漲5.12%報5.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617544306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617544306?lang=zh_tw&edition=fundamental","pubTime":"2026-03-04 23:50","pubTimestamp":1772639400,"startTime":"0","endTime":"0","summary":"北京时间2026年03月04日23时50分，Artiva Biotherapeutics, Inc.股票出现波动，股价急速拉升5.12%。截至发稿，该股报5.75美元/股，成交量3.8538万股，换手率0.16%，振幅5.85%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.69%。其相关个股中，Can Fite Biopharma Ltd、Moolec Science Sa C/Wts 30/01/2028、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Can Fite Biopharma Ltd、Klotho Neurosciences, Inc.、Onconetix, Inc.较为活跃，换手率分别为2160.20%、59.34%、49.81%，振幅较大的相关个股有Moolec Science Sa C/Wts 30/01/2028、Klotho Neurosciences, Inc.、Can Fite Biopharma Ltd，振幅分别为114.71%、51.24%、41.60%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603042350019543045e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603042350019543045e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614735887","title":"Artiva Biotherapeutics, Inc.盤中異動 下午盤大幅拉升5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614735887","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614735887?lang=zh_tw&edition=fundamental","pubTime":"2026-02-27 03:50","pubTimestamp":1772135432,"startTime":"0","endTime":"0","summary":"北京时间2026年02月27日03时50分，Artiva Biotherapeutics, Inc.股票出现异动，股价快速拉升5.47%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.91%。其相关个股中，Curanex Pharmaceuticals Inc、Klotho Neurosciences Inc C/Wts 21/06/2029 、Pmv Pharmaceuticals, Inc.涨幅较大，Curanex Pharmaceuticals Inc、Cardio Diagnostics Holdings Inc.、Kairos Pharma, Ltd.较为活跃，换手率分别为691.74%、146.98%、105.26%，振幅较大的相关个股有Curanex Pharmaceuticals Inc、Briacell Therapeutics Corp C/Wts 26/02/2026、Liminatus Pharma Inc C/Wts 30/04/2030 ，振幅分别为68.49%、63.48%、55.17%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc是一家生物制药公司。该公司的管道项目包括artiva资助的试验和合作者资助的试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227035033a4cca08e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227035033a4cca08e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128732813","title":"Artiva Biotherapeutics任命Thad Huston為首席財務官並授予入職獎勵股權","url":"https://stock-news.laohu8.com/highlight/detail?id=1128732813","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128732813?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 21:08","pubTimestamp":1771938499,"startTime":"0","endTime":"0","summary":"2026年2月24日，临床阶段生物技术公司Artiva Biotherapeutics, Inc.宣布任命Thad Huston担任首席财务官。该公司致力于为严重自身免疫性疾病和癌症患者开发有效、安全且可及的细胞疗法。Huston先生在资本配置、运营执行和全球商业化方面拥有丰富经验，将助力Artiva推进AlloNK在自身免疫疾病领域的应用，并构建具备长期价值创造能力的组织体系。Huston持有宾夕法尼亚州立大学金融学士学位，并拥有注册管理会计师资质。作为入职激励，Artiva董事会批准向Huston先生授予22万份限制性股票单位。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4022","ARTV","BK4232","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137215798","title":"Artiva Biotherapeutics任命Thad Huston為首席財務官並授予入職獎勵股權","url":"https://stock-news.laohu8.com/highlight/detail?id=1137215798","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137215798?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 21:05","pubTimestamp":1771938325,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics, Inc. (以下简称Artiva) 近日宣布，任命Thad Huston先生为公司首席财务官（CFO）。作为一项重要的高管入职激励措施，公司同时向Huston先生授予了相应的股权奖励。\nThad Huston在生物科技与制药行业拥有丰富的财务管理与资本运作经验，其加入将进一步加强Artiva在财务战略、资金管理及企业发展方面的领导力量。此次任命及股权授予符合公司吸引和保留顶尖人才的战略，旨在支持Artiva持续推进其细胞治疗产品管线的研发与商业化进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613485967","title":"Artiva Biotherapeutics, Inc.盤中異動 快速上漲6.20%報4.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613485967","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613485967?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 04:07","pubTimestamp":1771877243,"startTime":"0","endTime":"0","summary":"北京时间2026年02月24日04时07分，Artiva Biotherapeutics, Inc.股票出现异动，股价快速上涨6.20%。截至发稿，该股报4.97美元/股，成交量8.8478万股，换手率0.36%，振幅10.03%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Arcellx, Inc.、Klotho Neurosciences, Inc.、Vanda Pharmaceuticals Inc.涨幅较大，Genprex, Inc.、Psyence Biomedical Ltd.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为370.65%、237.08%、149.75%，振幅较大的相关个股有Abpro Holdings Inc C/Wts 12/11/2029 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Biovie Inc C/Wts 08/08/2030，振幅分别为70.43%、66.80%、49.38%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022404072497a6bd06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022404072497a6bd06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}]}}